Model solutions for ethical allocation during cancer medicine shortages.

Hantel, Andrew; Peppercorn, Jeff; Abel, Gregory A

Hantel, Andrew; Peppercorn, Jeff; Abel, Gregory A.

Hantel A; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Inpatient Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School Center for Bioethics, Boston, MA, USA.
Peppercorn J; Division of Oncology, Massachusetts General Hospital, Boston, MA, USA.
Abel GA; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School Center for Bioethics, Boston, MA, USA. Electronic address: gregory_abel@dfci.harvard.edu.

Lancet Haematol ; 8(4): e246-e248, 2021 04.

Article in English | MEDLINE | ID: covidwho-1213872

Subject(s)

Antineoplastic Agents/supply & distribution; Health Care Rationing/ethics; Hematologic Neoplasms/drug therapy; Resource Allocation/ethics; Antineoplastic Agents/economics; Clinical Decision-Making; Developing Countries/economics; Health Care Rationing/methods; Humans; Medical Oncology/ethics; Pharmacies/ethics; Pharmacies/organization & administration

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Care Rationing / Hematologic Neoplasms / Resource Allocation / Antineoplastic Agents Type of study: Prognostic study Limits: Humans Language: English Journal: Lancet Haematol Year: 2021 Document Type: Article Affiliation country: S2352-3026(21)00055-7

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google